We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.
- Authors
Charbonnel, Bernard; Karasik, Avraham; Liu, Ji; Wu, Mei; Meininger, Gary; Sitagliptin Study 020 Group
- Abstract
The efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, added to ongoing metformin therapy, were assessed in patients with type 2 diabetes who had inadequate glycemic control (HbA(1c) [A1C] >or=7 and <or=10%) with metformin alone.
- Publication
Diabetes care, 2006, Vol 29, Issue 12, p2638
- ISSN
0149-5992
- Publication type
Journal Article
- DOI
10.2337/dc06-0706